BALAXI PHARMA LTD
BALAXI · General/Diversified · NSE
₹23
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for BALAXI yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
4/9
Economic Moat
None
Confidence
4%
ROE
10.8%
Debt/Equity
0.23
WACC
11.1%
Market Cap
₹128.30 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
11.7%
Return on capital employed
EV / EBITDA
7.1×
Enterprise multiple
Debt / EBITDA
2.8×
Leverage vs earnings
Interest Coverage
10.8×
EBIT covers interest
Current Ratio
4.45×
Short-term liquidity
Asset Turnover
0.89×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-7.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
BALAXI · last 8 annual periods
ROE
10.8%
ROCE
11.7%
Operating Margin
—
Debt / Equity
0.23×
PE
12.7×
EV / EBITDA
9.6×
Historical Financials
BALAXI · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 NSE_XBRL | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹231 Cr | ₹279 Cr | ₹336 Cr | ₹241 Cr | ₹293 Cr | +6.0% |
| EBITDA | — | ₹55.2 Cr | ₹59.2 Cr | ₹5.8 Cr | ₹33.5 Cr | -11.7% |
| EBIT | ₹44.3 Cr | ₹54.7 Cr | ₹57.4 Cr | ₹3.7 Cr | — | -46.3% |
| PAT | ₹38.1 Cr | ₹47.7 Cr | ₹46.0 Cr | ₹-2.4 Cr | ₹25.1 Cr | -10.0% |
| EPS (diluted) | ₹38.14 | ₹47.66 | ₹45.40 | ₹-2.31 | — | — |
| CFO | ₹0.0 Cr | ₹34.1 Cr | ₹6.1 Cr | ₹4.9 Cr | ₹-35.0 Cr | — |
| CapEx | — | ₹-27.3 Cr | ₹-15.0 Cr | ₹-1.6 Cr | ₹-21.8 Cr | — |
| FCF | — | ₹6.8 Cr | ₹-8.9 Cr | ₹3.3 Cr | ₹-56.8 Cr | — |
| Total Assets | — | ₹176 Cr | ₹240 Cr | ₹258 Cr | ₹310 Cr | +15.2% |
| Total Debt | — | ₹3.6 Cr | ₹13.3 Cr | ₹19.4 Cr | ₹53.4 Cr | +95.8% |
| Shareholders' Equity | — | ₹113 Cr | ₹183 Cr | ₹201 Cr | ₹232 Cr | +19.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
BALAXI vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 LYKALABS LYKALABS | — | — | Pending | -10.9% | — |
 TAKE TAKE | — | — | Pending | — | — |
HALEOSLABS HALEOSLABS | — | — | Pending | 10.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
1 ex-dividend event on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹0.10/sh
Last payout
2022-07-01
₹0.10
Peak payout
₹0.10
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of BALAXI →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for BALAXI →
Compare
Head-to-head with peers
Compare BALAXI side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse BALAXINow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.